Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages):

	Three Months Ended June 30,						Six Months Ended June 30,
Net sales	2019			2018			2019			2018
MedSurg	$	818		$	751		$	1,584		$	1,462
Rhythm and Neuro	786			775			1,543			1,512
Cardiovascular	1,026			965			1,998			1,898
	$	2,631		$	2,490		$	5,124		$	4,870
	Three Months Ended June 30,						Six Months Ended June 30,
Income (loss) before income taxes	2019			2018			2019			2018
MedSurg	$	295		$	273		$	551		$	532
Rhythm and Neuro	167			160			322			313
Cardiovascular	301			300			577			590
Operating income of reportable segments	763			734			1,449			1,436
Corporate expenses, including hedging activities	(91		)	(100		)	(140		)	(200		)
Intangible asset impairment charges, acquisition-related, restructuring- and restructuring-related and litigation-related net (charges) credits	(127		)	(95		)	(64		)	(149		)
Amortization expense	(161		)	(147		)	(321		)	(288		)
Operating income (loss)	384			392			925			799
Other expense, net	(239		)	(45		)	(323		)	(129		)
Income (loss) before income taxes	$	145		$	347		$	602		$	670
Reportable segment operating income as a percentage of reportable segment net sales	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
MedSurg	36.1		%	36.4		%	34.8		%	36.4		%
Rhythm and Neuro	21.2		%	20.6		%	20.9		%	20.7		%
Cardiovascular	29.3		%	31.1		%	28.9		%	31.1		%